Αποτελέσματα Αναζήτησης
20 Αυγ 2020 · The FDA recalled hundreds of lots of losartan due to contamination with cancer-causing impurities. See the list of recalled losartan products, the reasons for the recall and the alternatives for treatment.
20 Οκτ 2021 · Search the full list of recalled angiotensin II receptor blockers (ARB) below by company, medicine, National Drug Code (NDC), lot number, or expiration date. Show entries. Export Excel. Company...
Some manufacturers are recalling some medications containing amlodipine in combination with valsartan or losartan, and some medications containing hydrochlorothiazide HCTZ in combination with...
21 Οκτ 2019 · As of August 2019—more than a year after the recalls began—the information currently available from FDA indicates the detectability of nitrosamines remains to be determined for all losartan, irbesartan, azilsartan, and eprosartan products currently marketed in the United States.
Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. This recall was prompted due to the detection of trace amounts of...
3 Οκτ 2019 · Losartan was recalled due to impurities found while testing finished products. The impurity found in these batches is N-Methylnitrosobutyric acid (NMBA). This is the third type of impurity to cause recalls of these medications.
Teva – Recall of losartan • On June 11, 2019, the FDA announced a consumer-level recall of Teva’s losartan tablets due to the detection of an impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), that is above the FDA’s interim acceptable exposure limit of 9.82 ppm.